News Impact
BAYZF· last 90 days
BAYER AG-REG
Backward-looking only. These statistics describe how the price moved after past news. They are not a prediction. Sample sizes are small, market context differs every day, and past performance does not predict future results. See methodology and disclaimer.
Bullish news (sentiment ≥ 0.3)
2articles
- Avg +24h
- +0.74%
- Avg +72h
- +0.74%
- Avg +7d
- -2.21%
Neutral news (−0.3 to 0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Bearish news (sentiment ≤ −0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Per-event price reaction · 2 events
- SeekingAlpha5/6/2026, 9:03:43 AMBayer to buy Perfuse Therapeutics in $2.45B deal, boosting ophthalmology pipelineSentiment0.50Relevance100%+24h+0.74%+72h+0.74%+7d-2.21%
- BusinessWire5/6/2026, 6:30:00 AMBayer to Acquire Perfuse Therapeutics to Complement Ophthalmology PipelineSentiment0.40Relevance100%+24h+0.74%+72h+0.74%+7d-2.21%
Not investment advice. See full disclaimer.